Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

2.
3.

Amino acid repetitions in the dihydropteroate synthase of Streptococcus pneumoniae lead to sulfonamide resistance with limited effects on substrate K(m).

Haasum Y, Ström K, Wehelie R, Luna V, Roberts MC, Maskell JP, Hall LM, Swedberg G.

Antimicrob Agents Chemother. 2001 Mar;45(3):805-9.

4.

Selection of resistant variants of respiratory pathogens by quinolones.

Sefton AM, Maskell JP, Williams JD.

Int J Antimicrob Agents. 1999 Jul;12(2):129-34.

PMID:
10418757
5.

In vitro activity of grepafloxacin against Haemophilus influenzae and Moraxella catarrhalis.

Maskell JP, Whiley AC, Sefton AM.

Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):293-5. No abstract available.

PMID:
9707317
6.

Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae.

Maskell JP, Sefton AM, Hall LM.

Antimicrob Agents Chemother. 1997 Oct;41(10):2121-6. Erratum in: Antimicrob Agents Chemother 2000 May;44(5):1411.

7.

The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.

Sefton AM, Maskell JP, Rafay AM, Whiley A, Williams JD.

J Antimicrob Chemother. 1997 Jun;39 Suppl B:57-62.

PMID:
9222071
8.

Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.

Williams JD, Maskell JP, Whiley AC, Sefton AM.

J Antimicrob Chemother. 1997 May;39 Suppl A:41-6.

PMID:
9511061
9.

Azithromycin in the treatment of periodontal disease. Effect on microbial flora.

Sefton AM, Maskell JP, Beighton D, Whiley A, Shain H, Foyle D, Smith SR, Smales FC, Williams JD.

J Clin Periodontol. 1996 Nov;23(11):998-1003.

PMID:
8951627
10.

Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogens.

Sefton AM, Maskell JP, Seymour AC, Minassian M, Williams JD.

J Antimicrob Chemother. 1996 Apr;37(4):803-8.

PMID:
8722546
11.

Electrophoretic analysis of the lipopolysaccharides of Bacteroides spp.

Maskell JP.

Antonie Van Leeuwenhoek. 1994;65(2):155-61.

PMID:
7979320
12.

Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.

Williams JD, Maskell JP, Shain H, Chrysos G, Sefton AM, Fraser HY, Hardie JM.

J Antimicrob Chemother. 1992 Jul;30(1):27-37.

PMID:
1331019
13.

Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.

Chen HY, Maskell JP, Powell M.

J Antimicrob Chemother. 1992 May;29(5):602-3. No abstract available.

PMID:
1385590
14.

Failure of two macrolide antibiotics to prevent post-extraction bacteraemia.

Cannell H, Kerawala C, Sefton AM, Maskell JP, Seymour A, Sun ZM, Williams JD.

Br Dent J. 1991 Sep 21;171(6):170-3.

PMID:
1832916
15.

Fine molecular specificity of linear and assembled antibody binding sites in HIV-1 p24.

Haaheim LR, Maskell JP, Mascagni P, Coates AR.

Scand J Immunol. 1991 Sep;34(3):341-50.

PMID:
1715604
16.
17.

Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin.

Maskell JP, Sefton AM, Cannell H, Kerawala C, Seymour A, Sun ZM, Williams JD.

J Antimicrob Chemother. 1990 Oct;26(4):539-48.

PMID:
2254223
18.

Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction.

Sefton AM, Maskell JP, Kerawala C, Cannell H, Seymour A, Sun ZM, Williams JD.

J Antimicrob Chemother. 1990 Jun;25(6):975-84.

PMID:
2196261
19.

Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.

Maskell JP, Sefton AM, Williams JD.

J Antimicrob Chemother. 1990 Jan;25 Suppl A:19-24.

PMID:
2154433
20.

In-vitro activity of lomefloxacin (SC-47111) and other quinolones.

Sun ZM, Maskell JP, Sehgal SC, Williams JD.

Infection. 1989 May-Jun;17(3):165-7.

PMID:
2737760
21.

Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.

Maskell JP, Tang T, Asad S, Williams JD.

J Antimicrob Chemother. 1989 Mar;23 Suppl C:65-74.

PMID:
2732145
22.

Comparative in vitro activity of A-56268.

Sefton AM, Maskell JP, Yong FJ, Chi SJ, Williams JD.

Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):798-802.

PMID:
2975218
23.

Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.

Maskell JP, Sefton AM, Yong J, Chi SJ, Williams JD.

Infection. 1988;16(6):365-70.

PMID:
3146552
24.

Erythromycin and gastrointestinal motility.

Zara GP, Qin XY, Pilot MA, Thomson HH, Maskell JP.

Lancet. 1987 Oct 31;2(8566):1036. No abstract available.

PMID:
2889954
25.

In-vitro susceptibility of oral streptococci to pristinamycin.

Maskell JP, Williams JD.

J Antimicrob Chemother. 1987 May;19(5):585-90.

PMID:
3112093
26.

Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs.

Qin XY, Pilot MA, Thompson HH, Maskell JP.

J Antimicrob Chemother. 1986 Dec;18(6):747-56.

PMID:
3818498
27.

The quantification of the neutralization of the action of antibiotics by cationic iron.

Miles AA, Maskell JP, Evans SJ.

J Antimicrob Chemother. 1986 Aug;18(2):185-93.

PMID:
3759729
28.

Teicoplanin as a prophylactic antibiotic for dental bacteraemia.

Maskell JP, Carter JL, Boyd RB, Williams RJ.

J Antimicrob Chemother. 1986 May;17(5):651-9.

PMID:
2941404
29.

The neutralization of antibiotic action by metallic cations and iron chelators.

Miles AA, Maskell JP.

J Antimicrob Chemother. 1986 Apr;17(4):481-7.

PMID:
3519562
30.

The antagonism of tetracycline and ferric iron in vivo.

Miles AA, Maskell JP.

J Med Microbiol. 1985 Aug;20(1):17-26.

PMID:
4020849
31.

The variable response of bacteria to free haemoglobin in the tissues.

Maskell JP, Miles AA.

J Med Microbiol. 1984 Dec;18(3):377-84.

PMID:
6438325
32.
33.

Detection of PSE-2 beta-lactamase in enterobacteria.

Livermore DM, Maskell JP, Williams JD.

Antimicrob Agents Chemother. 1984 Feb;25(2):268-72.

34.

Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.

Maskell JP, Nasu M, Williams JD.

J Antimicrob Chemother. 1984 Jan;13(1):23-30.

PMID:
6607916
35.

In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.

Nasu M, Maskell JP, Williams RJ, Williams JD.

Antimicrob Agents Chemother. 1981 Oct;20(4):433-6.

36.

Enzyme-mediated resistance of Bacteroides fragilis to moxalactam.

Maskell JP, Nasu M.

Lancet. 1981 Mar 28;1(8222):733. No abstract available.

PMID:
6110951
38.

The functional interchangeability of enterobacterial and staphylococcal iron chelators.

Maskell JP.

Antonie Van Leeuwenhoek. 1980;46(4):343-51.

PMID:
7447437

Supplemental Content

Loading ...
Support Center